Clinical Trials Directory

Trials / Conditions / Untreated Hairy Cell Leukemia

Untreated Hairy Cell Leukemia

8 registered clinical trials studyying Untreated Hairy Cell Leukemia.

StatusTrialSponsorPhase
CompletedLenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphom
NCT02213913
University of ChicagoPhase 1 / Phase 2
TerminatedBrentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
NCT01805037
Northwestern UniversityPhase 1 / Phase 2
CompletedVaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing
NCT01588015
City of Hope Medical CenterPhase 1
CompletedBortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple
NCT02037256
Barbara Ann Karmanos Cancer InstituteN/A
CompletedDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surg
NCT00608361
National Cancer Institute (NCI)Phase 1
TerminatedSunitinib in Treating Patients With Idiopathic Myelofibrosis
NCT00387426
National Cancer Institute (NCI)Phase 2
CompletedAlvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Man
NCT00058227
National Cancer Institute (NCI)Phase 1
CompletedImatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
NCT00025415
National Cancer Institute (NCI)Phase 1